Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

China Bio-Med Regeneration Technology Limited

中國生物醫學再生科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8158) DELAY IN DESPATCH OF CIRCULAR

Reference is made to the announcements (the "Announcements") of China Bio-Med

Regeneration Technology Limited (the "Company") dated 10 November 2014 and 1

December 2014 in relation to the placing of new shares of the Company with grant of options which constitutes a connected transaction for the Company. Unless other expressly indicated, capitalised terms used herein shall have the same meaning as those defined in the Announcements.

As stated in the Announcements, a circular (the "Circular") containing, amongst other things, (i) further details of the Placing; (ii) a letter of advice from the Independent Board Committee to the Independent Shareholders in relation to the All Favour Placing; (iii) a letter of advice from Gram Capital to the Independent Board Committee and the Independent Shareholders in relation to the All Favour Placing; and (iv) a notice of EGM, is expected to be despatched to the Shareholders on or before 15 December 2014 in accordance with the GEM Listing Rules.

As additional time is required for the Company to finalise the information for inclusion in the Circular, it is expected that the despatch of the Circular will be further delayed to a date on or before 15 January 2015.

By Order of the Board

China Bio-Med Regeneration Technology Limited Dai Yumin

Executive Director

Hong Kong, 15 December 2014

1

As at the date of this announcement, the executive Directors are Mr. Dai Yumin and Ms. Wang Yurong; the non-executive Directors are Mr. Wong Sai Hung, Professor Deng Shaoping, Mr. Cao Fushun, Mr. Yang Zhengguo, Mr. Ma Long and Mr. Wang Jianjun; and the independent non-executive Directors are Mr. Lui Tin Nang, Mr. Chan Wing Hang, Mr. Pang Chung Fai Benny and Mr. Chan Bing Woon, SBS,

JP.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.
This announcement will remain on the "Latest Company Announcement" page of the GEM website at www.hkgem.com for at least seven days from the date of the publication and will be published on the website of the Company at www.bmregeneration.com.

2

distributed by